A Study of Ingested Cannabidiol in Healthy Occasional Cannabis Users

NCT05407285 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Cannabis

Interventions

DRUG: cannabis 0 mg, placebo
DRUG: Cannabis 20 mg,
DRUG: Cannabis 50 mg
DRUG: Cannabis 100 mg
DRUG: Cannabis 200 mg

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)